Track survodutide in Peptimes™
Survodutide (BI 456906) is an investigational drug: it is being studied in clinical trials, including Phase 3 trials sponsored by Boehringer Ingelheim. (Source: ClinicalTrials.gov.)
Is survodutide FDA-approved?
No. Survodutide is investigational: it's being studied in clinical trials and isn't FDA-approved for any use.
Survodutide
Also: BI 456906, BI456906
- Status label in the Peptimes Library
- Phase 3 Trials
- Routes in Peptimes
- Subcutaneous
- Updated
- 1 Nov 2026
US regulatory status
FDA status
Not FDA-approved for any use. Drugs@FDA lists no application with survodutide as an active ingredient.
Source: Drugs@FDA, checked 1 Nov 2026
Investigational
Yes.
Source: ClinicalTrials.gov, checked 1 Nov 2026
How to track it in Peptimes
Add survodutide in My Protocols and set the schedule you already follow: days of the week, times of day and a start date. Peptimes never suggests an amount when you log or schedule a dose. Its Library entry shows the status label “Phase 3 Trials”, which describes its investigational status. It isn’t an approval.
- Logging: the amount you took and how you feel.
- Injection sites: each dose records the site, and Insights shows where you’ve injected and how recently. It never suggests where to inject next.
- Reminders and history: reminders at your times, Dose History, the Calendar and CSV or JSON export work as described on the peptide tracker app page.
Peptimes is a tracking app, not medical advice. Talk to a licensed clinician about your treatment. Peptimes doesn’t sell survodutide or any other compound.
More sources
- NIH, ClinicalTrials.gov, LIVERAGE (NCT06632444), checked 1 Nov 2026: a Phase 3 study of survodutide sponsored by Boehringer Ingelheim, recruiting.
- NIH, ClinicalTrials.gov, studies of survodutide, checked 1 Nov 2026: registered studies, including Phase 3 studies, and the code name BI 456906.
- FDA, Drugs@FDA, checked 1 Nov 2026: no application lists survodutide as an active ingredient.
- FDA, Global Substance Registration System, Survodutide, checked 1 Nov 2026: a modified peptide, and the code name BI-456906.